Needle-Free Injection System Market: Current Analysis and Forecast (2022-2028)

The needle-free injection system market is expected to register a CAGR of approx. 13% over the period of 2022-2028. Needle-free injection technology (NFIT) refers to a wide range of drug delivery systems that propel drugs through the skin using forces such as Lorentz, shock waves, gas pressure, or electrophoresis, effectively eliminating the use of hypodermic needles. The user can administer highly viscous drug products more easily with these techniques than with traditional needle and syringe systems. This technology is beneficial not only to the pharmaceutical industry but also to the development of a better world. The user avoids many other issues by using this technology, such as the possibility of needle stick injuries or complications caused by multiple uses of a single needle. This technique is also very useful in mass immunization programmes. The growing demand for needle-free injection systems can be attributed to the increasing prevalence of diabetes across the globe. For instance, according to the World Health Organization, nearly 422 million people globally have diabetes, the majority living in low-and middle-income countries. it has also been estimated by the International Diabetes Federation that by 2045 nearly 700 million adults worldwide will have diabetes. Owing to the glaring statistics the rising prevalence of diabetes leads to higher demand for needle-free insulin injection which boosts the demand for the needle-free injection system across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the needle-free injection system market is anticipated to grow on account of the Increasing number of regulatory approvals. In addition, a rising preference for the self-administration of drugs and an increase in injectable drugs for treatment drive market growth. However, some of the restraints in the market including the huge development costs, as well as stringent device regulations are impeding the growth of this market all over the world.

PharmaJet, Crossject SA, Portal Instruments, NuGen Medical Devices Inc, Inovio Pharmaceuticals Inc, Antares Pharma, Inc, Ferring B.V., Medical International Technology Inc, InsuJet, Glide Pharmaceutical Technologies Limited are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, the fillable needle-free injectors segment accounted for a significant market share in 2020"

Based on the product, the needle-free injection system market is segmented into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to its high adoption rates and wide availability throughout the globe. Increasing the application of needle-free injections in vaccination, insulin and other drug delivery is likely to boost the segment of the market.

"Amongst technology, the jet-based needle-free injectors category is expected to witness considerable CAGR during the forecast period"

Based on the technology, the market is fragmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Benefits of this technology include faster drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.

"Amongst usability, the reusable needle-free injectors category is expected to witness considerable CAGR during the forecast period"

Based on the usability, the market is fragmented into disposable needle-free injectors and reusable needle-free injectors. The reusable needle-free injectors segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Reusable needle-free injectors are commonly recommended by healthcare professionals and doctors to reduce the risk of infections and other harmful ailments. Reusable injectors are extremely durable because they are made of superior and precision-engineered materials, allowing doctors to reuse them multiple times.

"Amongst applications, the vaccine delivery category is expected to witness considerable CAGR during the forecast period"

Based on the application, the market is fragmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increased preference for vaccine administration is expected to drive up demand for needle-free injectors. The growing prevalence of medical conditions such as pain disorders, arthritis, and migraine is expected to keep the market position.

"Amongst end-user, the hospitals' category is expected to witness considerable CAGR during the forecast period"

Based on the end-user, the market is fragmented into home care settings, research laboratories, pharmaceutical and biotechnological companies, and others. The hospital segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. In nurse's stations, operating rooms, emergency rooms, outpatient departments, and ambulatory services, needle-free injectors are required in large quantities. For the procurement of such devices, hospitals typically hold an open tender. Growing patient hospitalisation, combined with an increase in the number of hospitals around the world, is expected to contribute to market growth during the forecast period.

"North America accounted for a significant market share in 2020"

For a better understanding of the market adoption of the needle-free injection system, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the needle-free injection system industry owing presence of highly regulated and developed healthcare infrastructure, the availability of advanced products due to the presence of major market players in the U.S. coupled with the increasing prevalence of chronic and lifestyle-associated diseases, rising healthcare spending in this region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global needle-free injection system market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.